Results 151 to 160 of about 23,676 (191)

Population Pharmacokinetics of Cabozantinib: Updated Analyses Including Data in Combination With Atezolizumab in Patients With Castration‐Resistant Prostate Cancer and Other Tumor Types

Clinical and Translational Science, Volume 19, Issue 10, October 2026.
ABSTRACT Cabozantinib is a small‐molecule tyrosine kinase inhibitor approved for the treatment of various locally advanced or metastatic solid tumors. The phase 1b COSMIC‐021 study evaluated cabozantinib as a monotherapy or in combination with atezolizumab in patients with advanced solid tumors, including castration‐resistant prostate cancer (CRPC ...
Jason H. Williams, Hanbin Li, Ahmed A. Othman   +2 more
wiley   +1 more source

Synergistic role of molecular imaging and genomics in thyroid cancer management: from diagnosis to personalized treatment. [PDF]

J Transl Med
Ahmadi S, Hoseini M, Ravari MS, Zarei M, Shahrokhi P, Mousavi P.   +5 more
europepmc   +1 more source

Proteomic profiling identifies candidate biomarkers for small intestinal neuroendocrine tumours G1 and G2

Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Although small intestinal neuroendocrine tumours (SI‐NET) Grade 1 (G1) and 2 (G2) are often studied together, clinical course and response to treatment may differ. We hypothesized that these tumour groups express different markers in blood that may inform future treatment strategies. Blood from 107 SI‐NET patients (G1 n = 64, G2 n = 43) and 50
Malin Grönberg, Dimitrios Papantoniou, Eva Tiensuu Janson   +2 more
wiley   +1 more source

How to manage radioiodine-refractory thyroid cancer in the era of precision medicine. [PDF]

Drugs Context
Karapanou O, Effraimidis G, Michalaki M, Saltiki K.   +3 more
europepmc   +1 more source

Nucleic Acids as Emerging Regulators of Calcium Phosphate Biomineralization

The FASEB Journal, Volume 40, Issue 17, 15 September 2026.
Calcium phosphate biomineralization has traditionally been considered a protein‐regulated process. This review highlights the emerging role of nucleic acids, which interact with mineral phases through adsorption, coprecipitation, and templating, thereby influencing crystal nucleation and growth.
Fanny Duhalde, Jessem Landoulsi, Xavier Houard   +2 more
wiley   +1 more source

Acquired TPM3::NTRK1 fusion as a novel off-target resistance mechanism to selpercatinib in RET-positive lung adenocarcinoma: a case report. [PDF]

Front Oncol
Choudhury R, Sharma M, Dewan A, Choudhary SK, Venkatraman P, Subbiah V, Batra U.   +6 more
europepmc   +1 more source

Radioiodine-Refractory Differentiated Thyroid Cancer: Definition, Molecular Mechanisms, and Advances in Precision Therapy. [PDF]

Cancer Innov
Li Y, He Z.
europepmc   +1 more source

Modern therapeutic approaches in cholangiocarcinoma: A narrative review of key biomarkers and clinical trials. [PDF]

Transl Oncol
Almeida A, Manzi J, Hoff C, Kadri H, Livingstone A, Gleisner A, Toegel EB, Schulick R, Hoff PM, Vianna R, Abreu P.   +10 more
europepmc   +1 more source

Signaling pathways and targeted therapy in high‑risk refractory thyroid cancer: From bench to bedside (Review). [PDF]

Int J Oncol
Wang J, Liu Z, Zhang Q, Sun W.
europepmc   +1 more source

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: <i>How to manage thyroid diseases: from autoimmunity to malignancy</i> Special Issue. [PDF]

Drugs Context
Saltiki K, Effraimidis G.
europepmc   +1 more source